Mometasone furoate was patented in 1981 and came into medical use in 1987.[8] It is available as a generic medication.[9] A month supply of the inhaler in the United Kingdom costs the NHS about £30 while the nasal spray is less than £2, as of 2019.[9] In 2017, it was the 197th most commonly prescribed medication in the United States, with more than two million prescriptions.[10][11]